Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

BACKGROUND: Recent studies strongly suggest that due to the limitations and risks of biopsy, as well as the improvement of the diagnostic accuracy of biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT),...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Comp Hepatol
Autori principali:	Poynard, Thierry, Imbert-Bismut, Françoise, Munteanu, Mona, Messous, Djamila, Myers, Robert P, Thabut, Dominique, Ratziu, Vlad, Mercadier, Anne, Benhamou, Yves, Hainque, Bernard
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2004
Soggetti:	Research
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522750/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15387887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-5926-3-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!